A very small proportion of Ph-positive CML patients display a larger BCR-ABL1 fusion transcript that results from a fusion between BCR exon 19 (originally named c3) and ABL exon 2. The gene discussed is BCR; the disease is chronic myelogenous leukemia, BCR-ABL1 positive.